m.salgado
Submits third-party assay reports on material purchased directly. Based in Monterrey.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.11%
n=9
Suppliers covered
6
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041485 | CJC-1295 (no DAC) | QSC | QSC-2601-B6118 | PeptideMeter | 2026-Q2 | 99.15 | 5.02 | 102.7 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042295 | Semaglutide | TFC | TFC-2508-A1033 | Janoshik | 2026-Q1 | 99.11 | 3.54 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018431 | GHRP-6 | WWB | WWB-2511-C2485 | Janoshik | 2025-Q4 | 99.79 | 4.63 | 105.2 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-018466 | Tirzepatide | WWB | WWB-2506-T2732 | PeptideMeter | 2025-Q4 | 99.27 | 3.73 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018690 | Tirzepatide | QSC | QSC-2511-S6768 | Janoshik | 2025-Q4 | 99.64 | 4.51 | 94.2 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-021094 | Semaglutide | BCH | BCH-2505-Y5388 | Nordanalyt | 2025-Q4 | 98.14 | 6.41 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019965 | Retatrutide | HJ | HJ-2412-C6855 | VendorInvestigate | 2025-Q2 | 97.98 | 3.65 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005253 | BPC-157 | BCH | BCH-2406-Y4179 | Janoshik | 2024-Q3 | 97.97 | 5.77 | 93.6 | Buyer-sourced | 0 | FAIL |
| AX-2024-005007 | Semaglutide | KP | KP-2405-C4939 | Janoshik | 2024-Q3 | 97.90 | 4.69 | — | Buyer-sourced | 0 | PASS |